Xiaoju Wang

6.9k total citations · 2 hit papers
49 papers, 3.8k citations indexed

About

Xiaoju Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Xiaoju Wang has authored 49 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Xiaoju Wang's work include Prostate Cancer Treatment and Research (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Protein Degradation and Inhibitors (6 papers). Xiaoju Wang is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Protein Degradation and Inhibitors (6 papers). Xiaoju Wang collaborates with scholars based in China, United States and Australia. Xiaoju Wang's co-authors include Arul M. Chinnaiyan, Xuhong Cao, Irfan A. Asangani, Xiaojun Jing, John T. Wei, Sooryanarayana Varambally, Felix Y. Feng, Kenneth J. Pienta, Qi Cao and Debashis Ghosh and has published in prestigious journals such as Nature, New England Journal of Medicine and Nature Communications.

In The Last Decade

Xiaoju Wang

46 papers receiving 3.7k citations

Hit Papers

Transcriptome sequencing across a prostate cancer cohort ... 2011 2026 2016 2021 2011 2014 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoju Wang China 23 2.8k 1.2k 935 598 531 49 3.8k
Ricardo M. Attar United States 30 1.7k 0.6× 652 0.5× 827 0.9× 385 0.6× 877 1.7× 72 3.2k
Dale L. Ludwig United States 36 4.4k 1.6× 993 0.8× 850 0.9× 689 1.2× 1.6k 3.1× 91 5.9k
Pieter J.A. Eichhorn Singapore 25 2.7k 1.0× 682 0.5× 525 0.6× 285 0.5× 1.3k 2.5× 34 3.6k
Sankar N. Maity United States 39 3.1k 1.1× 965 0.8× 808 0.9× 176 0.3× 838 1.6× 84 4.4k
Diane L. Persons United States 29 1.4k 0.5× 608 0.5× 409 0.4× 412 0.7× 1.3k 2.5× 64 3.1k
Carrie Rinker‐Schaeffer United States 34 2.6k 0.9× 670 0.5× 798 0.9× 199 0.3× 1.1k 2.1× 73 3.8k
Edward Fox United States 32 2.1k 0.8× 1.3k 1.0× 299 0.3× 213 0.4× 802 1.5× 94 4.1k
Yun Wu United States 36 2.1k 0.7× 1.8k 1.4× 870 0.9× 372 0.6× 2.5k 4.6× 105 5.2k
Howard B. Lieberman United States 34 2.6k 0.9× 635 0.5× 483 0.5× 572 1.0× 901 1.7× 73 3.5k
Hartmut Juhl United States 26 2.1k 0.8× 2.0k 1.6× 623 0.7× 292 0.5× 1.2k 2.2× 65 3.8k

Countries citing papers authored by Xiaoju Wang

Since Specialization
Citations

This map shows the geographic impact of Xiaoju Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoju Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoju Wang more than expected).

Fields of papers citing papers by Xiaoju Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoju Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoju Wang. The network helps show where Xiaoju Wang may publish in the future.

Co-authorship network of co-authors of Xiaoju Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoju Wang. A scholar is included among the top collaborators of Xiaoju Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoju Wang. Xiaoju Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jiacheng, et al.. (2025). Efficacy and safety of PD-1/PD-L1 inhibitors for relapsed/metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis. Letters in Drug Design & Discovery. 22(8). 100128–100128.
2.
Tu, Linglan, et al.. (2022). Uricase sensitizes hepatocellular carcinoma cells to 5-fluorouracil through uricase-uric acid-UMP synthase axis. Journal of Physiology and Biochemistry. 78(3). 679–687. 2 indexed citations
3.
Zeng, Shenxin, Dongmei Yan, Linglan Tu, et al.. (2021). Cytarabine and EIP co-administration synergistically reduces viability of acute lymphoblastic leukemia cells with high ERG expression. Leukemia Research. 109. 106649–106649. 2 indexed citations
4.
Zhang, Yanmei, et al.. (2017). Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer. Scientific Reports. 7(1). 40786–40786. 24 indexed citations
5.
Sun, Peibei, et al.. (2017). E-26 Transformation-specific Related Gene Expression and Outcomes in Cytogenetically Normal Acute Myeloid Leukemia. Chinese Medical Journal. 130(12). 1481–1490. 4 indexed citations
6.
Yan, Dongmei, et al.. (2017). WBSCR22 confers oxaliplatin resistance in human colorectal cancer. Scientific Reports. 7(1). 15443–15443. 43 indexed citations
7.
Li, Weili, Wenzhe Wang, Mingjian Ding, et al.. (2016). MiR-1244 sensitizes the resistance of non-small cell lung cancer A549 cell to cisplatin. Cancer Cell International. 16(1). 30–30. 43 indexed citations
8.
Ma, Shenglin, Wenzhe Wang, Bing Xia, et al.. (2016). Multiplexed Serum Biomarkers for the Detection of Lung Cancer. EBioMedicine. 11. 210–218. 25 indexed citations
9.
Wang, Wenzhe, Weili Li, Mingjian Ding, et al.. (2016). Identification of miRNAs as non-invasive biomarkers for early diagnosis of lung cancers. Tumor Biology. 37(12). 16287–16293. 12 indexed citations
10.
Ji, Peng, Ling Yu, Xiaoju Wang, et al.. (2015). Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 22(4). 185–191. 20 indexed citations
11.
Cao, Qi, Xiaoju Wang, Meng Zhao, et al.. (2014). The central role of EED in the orchestration of polycomb group complexes. Nature Communications. 5(1). 3127–3127. 119 indexed citations
12.
Jia, Jing, Xiaoli Liu, Yongxia Chen, et al.. (2013). Establishment of a pancreatic β cell proliferation model in vitro and a platform for diabetes drug screening. Cytotechnology. 66(4). 687–697. 2 indexed citations
13.
Wang, Xiaoju. (2012). A Laser Beam Shaping Optical System for Laser Fuze. 1 indexed citations
14.
Seder, Christopher W., Guoan Chen, Xiaoju Wang, et al.. (2008). AZGP1 Autoantibody Predicts Survival and Histone Deacetylase Inhibitors Increase Expression in Lung Adenocarcinoma. Journal of Thoracic Oncology. 3(11). 1236–1244. 44 indexed citations
15.
Chen, Guoan, Xiaoju Wang, Jianjun Yu, et al.. (2007). Autoantibody Profiles Reveal Ubiquilin 1 as a Humoral Immune Response Target in Lung Adenocarcinoma. Cancer Research. 67(7). 3461–3467. 73 indexed citations
16.
Yu, Jindan, Jianjun Yu, Daniel R. Rhodes, et al.. (2007). A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome. Cancer Research. 67(22). 10657–10663. 251 indexed citations
17.
Chatterjee, Madhumita, Saroj Kant Mohapatra, Alexei Ionan, et al.. (2006). Diagnostic Markers of Ovarian Cancer by High-Throughput Antigen Cloning and Detection on Arrays. Cancer Research. 66(2). 1181–1190. 165 indexed citations
18.
Wang, Xiaoju. (2006). Ecological and Environmental Effect of Road in Open Spaces: Problems and Strategies. Chinese Landscape Architecture. 1 indexed citations
19.
Bradford, Timothy, Xiaoju Wang, & Arul M. Chinnaiyan. (2006). Cancer immunomics: Using autoantibody signatures in the early detection of prostate cancer. Urologic Oncology Seminars and Original Investigations. 24(3). 237–242. 37 indexed citations
20.
Xu, Hui-lian, et al.. (1998). Corn Leaf Water Retention as Affected by Organic Fertilizations and Effective Microbes Applications. Pedosphere. 8(1). 1–8. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026